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IMPROVING IMAGE ACQUISITION FOR SIDESTREAM DARKFIELD IMAGING
OF THE MICROCIRCULATION BY A DISTANCING IMMOBILIZING DEVICE
G. Balestra1,2, Z.-Y. Yong3, R. Bezemer1, K. Sjauw3, A. Engstrom3, E. C. Boerma1,4,
C. Ince1
1Department of Translational Physiology, Academic Medical Center at the University of
Amsterdam, Amsterdam, The The Netherlands, 2Department of Internal Medicine and
Medical Intensive Care Unit, University Hospital Basel, Basel, Switzerland, 3Department of
Cardiology, Academic Medical Center at the University of Amsterdam, Amsterdam, The The
Netherlands, 4Department of Intensive Care Medicine, Medical Center Leeuwarden, Leeu-
warden, The Netherlands
INTRODUCTION. Sidestream darkfield imaging (SDF) is widely used for investigating the
microcirculation in critically ill patients. Maintaining image stability and avoiding pressure
artifacts (PA) are the major operational issues in SDF. However, a significant amount of
recordings are not suitable for analysis when reviewed in the post-processing, even when they
had been acquired by trained operators.
OBJECTIVES. The aim of the study was to investigate the effects of the DID on the
induction of PA, the alteration of flow patterns and the duration of imaging the sublingual
microcirculation with SDF.
METHOD. Five healthy, awake volunteers were examined by four experienced operators.
Through a redesigned stainless steel distancing immobilizing device (DID) [1], consisting of a
hollow ring with 20 concave outlets mounted on SDF disposables and exceeding them by
100 lm, suction can be applied to the tissue. The force required to cause slowed or stopped
flow of venules, thus inducing PA, was measured by gradually lowering a SDF imaging unit
hanging on a spring balance. The time to acquire a stable image, the duration of pressure
artifact-free stable image (x/y axis-translation \ 40 lm) and influence on flow patterns of the
imaged vessels were assessed with AVA 3.0 (Microvision Medical, Amsterdam, The Neth-
erlands). Flow patterns were assessed by switching the suction on and off.
RESULTS. PA were induced at a significant higher force with DID 0.063 N (SD 0.01) versus no
DID 0.023 N (SD 0.01) (P = 0.016). Flow was found not to be different with the suction turned
on in small (on 328 vs. off 304 lm/s; P = 0.23), medium (283 vs. 291 lm/s; P = 0.84) and
large vessels (311 vs. 366 lm/s; P = 0.38). The time required until the SDF image was stable
amounted to 98.7 s (SD 62.7) without and 150.4 s (SD 82) with DID (P = 0.124). SDF image
was kept stable for 7.96 s (SD 5.9) without and 41.56 s (SD 27.4) with DID (P \ 0.001).
CONCLUSION. When imaging with DID higher pressures on the tissue are tolerated before
PA are induced. Furthermore longer image stability is achieved. Both facts provide not only
increased yield of analyzable images but also the opportunity for longitudinal observation on
one specific area of the microcirculation during intervention studies.
REFERENCE. 1. Lindert J, Werner J, Redlin M et al. (2002) OPS imaging of human
microcirculation: a short technical report. J Vasc Res 39:368–372.
GRANT ACKNOWLEDGEMENT. None.
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IS THERE A CORRELATION BETWEEN NEAR INFRARED SPECTROSCOPY
AND SIDE DARK FIELD IMAGING?
Favory1, G. Ospina-Tascon1, K. Donadello1, D. Simion1, A. P. Neves1, G. Occhipinti1,
T. Oliveira1, A. Fonseca1, J. Creteur1, J.-L. Vincent1, D. De Backer1
1Erasme University Hospital, Universite´ Libre de Bruxelles, Intensive Care Unit, Brussels,
Belgium
BACKGROUND. A growing body of evidence suggests implication of microcirculatory
dysfunction in numerous diseases. The use of sidedark field (SDF) imaging and near infrared
spectroscopy (NIRS) associated with a vascular occlusion test (VOT) have been proposed to
assess microcirculation at the bedside. In sepsis, alterations in both types of measures are
associated with a poor outcome [1, 2]. However these techniques may provide different
information: SDF provides a direct look of the microvascular network whereas VOT gives
more dynamic informations. We evaluated whether data obtained simultaneously with NIRS
and SDF imaging in critically ill patients may be related.
MATERIALS AND METHODS. For NIRS (Inspectra, Hutchinson Technology, Hutchinson,
MN, USA) we performed a 3 min VOT using a tourniquet, and we recorded: descending slope of
StO2, ascending slope, StO2 at baseline and at its maximal value after the tourniquet release. To
visualize the microcirculation in the sublingual area we used a SDF imaging device (MicroScan;
MicroVision Medical, Amsterdam, The The Netherlands) with emphasis on the FCD calculated
as the number of small vessels (\ 20 lm) crossing lines of the grid divided by the total length of
the grid and the proportion of small vessels perfused (PPV). Linear correlation was used.
RESULTS. We analyzed a total of 95 concomitant measures of NIRS and SDF in 51 patients (41
with severe sepsis or septic shock). We found no significant correlation between basal StO2 and
FCD (r2 = 0.01, P = 0.44) or PPV (r2 = 0.02, P = 0.11), StO2 max and FCD (r2 = 0.02,
P = 0.23) and PPV (r2 = 0.02, P = 0.15), descending slope and FCD (r2 = 0.01, P = 0.96) or
PPV (r2 = 0.01, P = 0.28), ascending slope and FCD (r2 = 0.03, P = 0.08) and PPV
(r2 = 0.01, P = 0.44). See figure for point cloud of ascending slope and PPV for the 95 measures.
CONCLUSION. We failed to demonstrate any significant correlation between data obtained
with NIRS and SDF in critically ill patients. These two techniques explore different variables
in different regions of the body. Both have prognostic implications and can provide com-
plementary information.
REFERENCE. 1. Creteur ICM 2007. 2. Sakr CCM 2004.
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USE OF NEAR-INFRARED SPECTROSCOPY ON FINGER DURING A VASCULAR
OCCLUSION TEST TO ASSESS THE DYNAMIC TISSUE O2 SATURATION RESPONSE
A. Lima1, M. Alamyar1, J. Bakker1
1Erasmus MC University Medical Centre Rotterdam, Intensive Care, Rotterdam, The Netherlands
INTRODUCTION. Near-infrared spectroscopy (NIRS) in combination with a vascular
occlusion test (VOT) has been proposed to assess and identify metabolic and microcirculatory
alterations during sepsis and shock in critically ill patients. For the analysis of changes in the
tissue O2 saturation (StO2) during a circulatory stress test, the sphygmomanometer is usually
placed on the upper arm and the StO2 is measured over the thenar eminence. However, to
automatize repeated measurements at the bedside, this technique can potentially cause dis-
comfort to the patient. Vascular arterial occlusion in the finger may be a more attractive
method to perform repeated measurements at the bedside because of patient tolerability.
OBJECTIVE. To investigate whether vascular occlusion performed in the finger can be used
as a surrogate for vascular occlusion in the upper arm to assess the dynamic StO2 response.
METHODS. StO2 was non-invasively measured in 11 healthy volunteers during VOTs using
two InSpectra Tissue Spectrometers (model 650) equipped with a 15-mm or a 10-mm probe.
The 15-mm probe was placed over the thenar eminence and the 10-mm probe was place over
the ventral face of the middle finger. We performed in each subject a series of three vascular
occlusion tests on the finger (3, 5 and 10 min) followed by one on the arm (3 min). VOT-
derived StO2 traces were analyzed for baseline, ischemic and reperfusion parameters.
RESULTS. The general results of VOT in the finger and in the arm are shown in the following table:
DYNAMIC STO2 RESPONSE DURING VOT
Measurement site Arm Finger Finger Finger
Probe 15 mm 10 mm 10 mm 10 mm
Vascular occlusion time 3 min 3 min 5 min 10 min
Baseline (%) 82 ± 3a 89 ± 10 91 ± 10 92 ± 17
Down-slope (% per min) -10 ± 3 -8.5 ± 2 -8.7 ± 2.6 -8.1 ± 2
Down-slope fit (R2) 0.98 ± 0.01 0.96 ± 0.02 0.98 ± 0.01 0.98 ± 0.01
Up-slope(% s) 4 ± 1.3a 1.2 ± 0.5 1.7 ± 0.9 2.3 ± 1.5b
Up-slope fit (R2) 0.98 ± 0.01 0.92 ± 0.04 0.96 ± 0.02b 0.95 ± 0.02b
AUC Ischemic (% per min) 46 ± 14 32 ± 11 84 ± 41c 194 ± 55c
aP \ 0.05 versus finger (3, 5, 10 min)
bP \ 0.05 versus finger 3 min
cP \ 0.05 versus thenar
StO2 baseline and StO2 up-slope in the finger differed significantly from the arm. No difference
in the StO2 down-slope was found between arm and finger. Based on the curve fit (R2) for both
StO2 slopes, the best occlusion time in the finger to study NIRS-dynamic variables was 5 min.
CONCLUSION. Near-infrared spectroscopy can be used on finger to assess the StO2
response to vascular occlusion test. Our results showed that 5 min is an adequate occlusion
time to provide the best curve fit for NIRS dynamic variables.
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EFFECTS OF SODIUM HYDROSULPHIDE ON HEMODYNAMICS, INFLAMMA-
TORY RESPONSE AND OXIDATIVE STRESS DURING RETRANSFUSED
HEMORRHAGIC SHOCK IN RATS
F. Ganster1,2, M. Burban2, M. De la Bourdonnaye2, L. Fizanne2, L. Loufrani3, A. Mercat1,2, P.
Cale`s2,4, P. Radermacher5, D. Henrion3, P. Asfar1,2, F. Meziani1,6
1CHU Angers, De´partement de Re´animation Me´dicale et Me´decine Hyperbare, Angers,
France, 2Universite´ d’Angers, Laboratoire HIFIH, UPRES EA 3859, IFR 132, Angers,
France, 3Universite´ d’Angers, INSERM UMR 771; CNRS UMR 6214, Angers, France, 4CHU
Angers, Service d’He´pato-Gastroente´rologie, Angers, France, 5Universita¨tsklinikum Ulm,
Sektion Ana¨sthesiologische Pathophysiologie und Verfahrensentwicklung, Ulm, Germany,
6Universite´ de Strasbourg, Faculte´ de Pharmacie, Laboratoire de Biophotonique et Pharma-
cologie, UMR 7213 CNRS, Illkirch, France
INTRODUCTION. Pre-treatment with hydrogen sulfide (H2S), was shown to improve sur-
vival in rodent models of otherwise lethal hypoxia or hemorrhage [1]. H2S, however, has also
vasodilatory properties, and inhibition of endogenous H2S production improved hemody-
namics and thereby reduced organ injury after hemorrhagic shock. Since all these data
originate from unresuscitated hemorrhage [2], we therefore tested the hypothesis that the H2S
donor sodium hydrosulfide (NaHS) would improve hemodynamics and attenuate oxidative
and nitrosative stresses after controlled hemorrhage and retransfusion.
METHODS. We randomly allocated 22 rats to either intravenous bolus of NaHS or vehicle
(0.9% saline). Rats were anesthetized, mechanically ventilated, and instrumented to measure
heart rate, mean arterial pressure (MAP) and carotid blood flow. Animals were bled during
60 min to maintain MAP at 40 ± 2 mmHg and then, the shed blood was reinfused. The NaHS
group received a bolus of 0.2 mg/kg 10 min before retransfusion and the control group
received the same amount of vehicle. Hemodynamic parameters were monitored during
300 min every 10 min. Animals were then sacrificed. Blood, aorta and heart were harvested
for Western blot and electron paramagnetic resonance.
RESULTS. H2S significantly limited the decrease in MAP during reperfusion (Fig. 1).
NaHS significantly reduced the release of radical oxygen species after reperfusion. NaHS provided
protective effects by significantly reducing the inflammatory response induced by reperfusion (Fig. 2).
CONCLUSIONS. The results of our study demonstrate that NaHS, a H2S donor, is protective
against ischemia reperfusion injuries induced by controlled hemorrhage in rats.
REFERENCE. 1. Morrison ML et al. (2008) J Trauma. 2. Mok YY et al. (2004) Br J Pharmacol.
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THENAR OXYGEN SATURATION (STO2) MEASURED NON-INVASIVELY BY
NEAR-INFRARED SPECTROSCOPY DURING WEANING FROM MECHANICAL
VENTILATION. PRELIMINARY RESULTS
G. Gruartmoner1, J. Mesquida1, J. Masip1, M. L. Martinez1, F. Baigorri1, A. Artigas1
1Hospital de Sabadell, Critical Care Center. CIBER Enfermedades Respiratoria. Universitat
Autonoma de Barcelona, Sabadell, Spain
AIMS. To determine whether changes in tissue oxygen saturation (StO2) measured by near-
infrared spectroscopy (NIRS) on the thenar eminence, and its changes derived from an
ischemic challenge, can be used to predict success of weaning from mechanical ventilation.
METHODS. Prospective clinical study, performed in a 26-bed medical-surgical intensive
care unit, at a university-affiliated hospital. We recruited adult patients with acute respiratory
failure receiving mechanical ventilation for at least 48 h, and considered ready to wean by
their physicians. Patients underwent a 30 min spontaneous breathing trial (SBT). Continuous
StO2 was measured non-invasively on the thenar eminence. A transient arterial occlusion
proximal to the StO2 probe was performed twice (baseline, and at minute 30 of SBT).
Demographic data, StO2, gas exchange, ventilatory parameters and hemodynamic measure-
ments were recorded just before starting the trial, and during the trial.
RESULTS. Thirty patients were studied. Main variables measured are shown in Table 1. Five
patients did not succeed the SBT. Twenty-three patients succeed the SBT, and were extu-
bated. Two of these patients needed re-institution of MV within 24 h. Patients who failed the
overall weaning trial (n = 7) showed a significant increase in their thenar StO2 deoxygen-
ation rate (DeOx) during the ischemic challenge at minute 30 of SBT as compared to patients
who were successfully weaned (-25 ± 15 vs. -13 ± 3%/min, p 0.05). The ratio between the
30 min DeOx and the baseline DeOx (DeOx ratio) was also different between both groups of
patients (1.8 ± 0.7 vs. 1.0 ± 0.3, p 0.009). The DeOx ratio showed an AUC 0.88 (p 0.01) for
prediction of weaning success. A DeOx ratio cut-off value of 1.4 has a sensitivity 0.8,
specificity 0.94, for predicting weaning success.
MEASUREMENTS AT BASELINE AND MINUTE 30
Weaning success (n = 23) Weaning failure (n = 7)
Baseline Minute 30 Baseline Minute 30
MAP (mmHg) 82 ± 9 82 ± 15 81 ± 16 89 ± 23
RR (resp/min) 18 ± 3 23 ± 6 19 ± 2 29 ± 7
Vt (mL) 471 ± 88 470 ± 132 466 ± 60 335 ± 110
pH 7.46 ± 0.06 7.45 ± 0.08 7.46 ± 0.08 7.44 ± 0.03
pCO2 (mmHg) 34 ± 5 36 ± 7 36 ± 4 39 ± 4
StO2 (%) 81 ± 5 81 ± 6 76 ± 7 75 ± 8
DeOx (% per min) -16 ± 12 -13 ± 3 -15 ± 7 -25 ± 15*
DeOx ratio 1.04 ± 0.29 1.77 ± 0.69*
CONCLUSIONS. Weaning failure was associated with increased deoxygenation rate during
an ischemic challenge after 30 min of SBT. Measurement of StO2 and its changes during
transient arterial occlusion might be helpful in predicting weaning outcome.
Nosocomial infections: 0797–0801
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SEVEN-YEAR TRENDS IN MICROBIOLOGICAL ISOLATES AND ANTIBIOTIC
RESISTANCE IN A MIXED MEDICAL-SURGICAL ITALIAN INTENSIVE CARE UNIT
P. Calzavacca1, M. Barazzetta2, W. Schmidt1, F. Vitali2, S. Guidolin3, M. Solca4
1Ospedale Uboldo, Anaesthesia and Intensive Care Department, Cernusco sul Naviglio, Italy,
2Ospedale Uboldo, Laboratory and Microbiology Department, Cernusco sul Naviglio, Italy,
3Ospedale Uboldo, Head of Laboratory and Microbiology Department, Cernusco sul Navi-
glio, Italy, 4Ospedale Uboldo, Head of Anaesthesia and Intensive Care Department, Cernusco
sul Naviglio, Italy
AIMS. Sepsis is common in intensive care units (ICU) and carries high morbidity and
mortality. Antibiotics are widely used and can induce selection of resistant strains. Micro-
biology is important to guide treatment: in particular, WHO’s infection surveillance
guidelines recommend strict epidemiological surveillance to guide empiric treatment.
Accordingly, in our institution epidemiological information on type and characteristics of
germs are monitored and prospectively recorded since 1993.
METHODS. Prospective observational study in the five bed ICU of an Italian non-teaching
hospital. Patients were taken specimens at ICU admission and twice weekly thereafter.
Microbiology provided periodical electronic reports of isolates and antibiotic susceptibility.
RESULTS. There were 984 ICU admissions between 2002 and 2008: 60% were medical patients
while 40% were surgical; 27% were suspected to be septic at admission and 15% developed sepsis
during ICU stay. Median ICU length of stay was 4 days. ICU mortality was 24% and hospital
mortality 27%.
Figure 1 depicts the seven-year trend of relevant specimens. It is a known phenomenon that
gram? and gram- prevalence has a cyclic pattern. Our study is in accordance with this
finding. However, this seemed to change in 2006–2007 when both gram? and gram- isolates
showed a decreasing trend, replaced by fungi.
Figure 2 shows pattern of resistance to antibiotics of four common bacteria in ICU:
methicillin resistant Staphylococcus aureus (MRSA), carbapenems resistant Pseudomonas
aeruginosa and ESBL (extended spectrum beta-lactamases) Escherichia coli and Klebsiella
pneumoniae. High level of MRSA were observed throughout the period, but in the last 2 years
resistance almost halved. Lowest level of ESBL and carbapenems resistance was observed
when highest was the incidence of gram- germs.
CONCLUSIONS. This study confirms other studies in EU Countries about the rise in fungi in
ICU patients’ isolates and the high prevalence of MRSA.
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IMPACT OF SHORT TERM FOCUSED EDUCATION INTERVENTION ON ICU
NURSES’ AWARENESS OF INFECTION CONTROL MEASURES, ICU HAND
WASHING PRACTICES AND NOSOCOMIAL INFECTIONS
M. Sircar1, R. Gupta1, A. Kumar1, A. Gupta1, H. Vohra1, N. Chavhan1, A. Anchal1,
S. Sengupta2, K. Joseph3
1Fortis Hospital, Pulmonology and Critical Care, Noida, India, 2Fortis Hospital, Microbiol-
ogy, Noida, India, 3Fortis Hospital, Nursing, Noida, India
INTRODUCTION. A statistically non-significant increase in nurses’ awareness of infection
control measures has been reported after a month of focused education [1]. Indian Intensive
Care Units (ICU) have reported high acquired infection rates [2]. Education can improve
infection control in ICU [3]. We evaluated baseline nurses’ awareness about infection control
measures and the impact of 3–4 months long focused education.
METHODS. Awareness of infection control measures amongst ICU nurses of Fortis Hos-
pital, NOIDA, UP, India was assessed using multiple choice questions (MCQ) at baseline,
after one month and 3–4 months of focused education intervention in form of lectures and
bedside training. The incidence of ventilator associated pneumonia (VAP), catheter associated
blood stream infection (CABSI), catheter associated urinary tract infections (CAUTI), and
alcohol–chlorhexidine hand rub utilization was recorded for 3 months prior and 3 months
after the initial month of the intervention. The results were statistically analyzed.
RESULTS. Mean ± SD 41.94 ± 12.23% MCQ were correctly answered by 108 nurses
evaluated at baseline. After a month, 56 nurses answered 50 ± 12.86% MCQ correctly as
compared to baseline of 42.68 ± 13.94% (P = 0.0054) in the same subset. Similarly, after 3–
4 months of the intervention 64 nurses correctly responded to 50.78 ± 14.26% MCQ as
compared to their baseline of 44.37 ± 12.05% (P = 0.0058). Only 57 nurses could be tested
both at one and 3–4 months after intervention and correctly responded to 48.24 ± 12.08 and
51.92 ± 14.52% MCQ respectively (P = 0.058, NS). High dropout rate after initial evalu-
ation was mainly due to nurses leaving the hospital. Mean ± SD VAP, CABSI and CAUTI
(per 1,000 device days), 3 months before and 3 months after initial month of intervention,
were 24.95 ± 8.16 and 12.74 ± 15.33 (P = 0.145); 4.63 ± 1.98 and 5.76 ± 2.43
(P = 0.298) and 4.05 ± 1.64 and 3.59 ± 1.58 (P = 0.37) respectively. An MDR Acineto-
bacter outbreak occurred during 2nd month of intervention, which was quickly contained
within the same month. Mean ± SD hand rub utilization per patient ICU day, 3 months
before and 3 months after initial month of intervention were 87.17 ± 26.14 and
141.59 ± 21.33 ml respectively (P = 0.024).
CONCLUSIONS. At baseline, less than half MCQ were correctly answered by the nurses.
After focused education intervention, nurses’ awareness significantly improved. Post-inter-
vention there was a 48.94% decrease in mean VAP rates although this did not reach statistical
significance. Acinetobacter outbreak during the second month, though rapidly contained,
could have masked the improvements. Hand rub utilization significantly improved, suggesting
better hand washing compliance and this may have contributed to reduction in infection rates.
REFERENCE(S). 1. Intensive Care Med 2008; 34(suppl 1):S232. 2. J Hosp Infect. 2007;
67(2):168. 3. Clin Infect Dis. 2007; 45:704.
GRANT ACKNOWLEDGEMENT. None.
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PREOPERATIVE RISK FACTORS ON SURGICAL WOUND INFECTION. MULTI-
CENTRE STUDY IN 59 CATALONIAN HOSPITALS
L. Contreras1, L. Garcia-Huete1, V. Mayoral1, A. Cabrera1, C. Ribes1, A. Montero1, J. Canet2
1Universitary Hospital of Bellvitge, Anesthesia, L’Hospitalet de Llobregat, Spain, 2Main
Project Researcher Germans Trias i Pujol Hospital, Anesthesia, Badalona, Spain
INTRODUCTION. Surgical wound infection is a common problem and represents an
important complication of surgery. Underlying patient pathology has a clear influence on
surgical wound infection occurrence.
OBJECTIVES. To establish surgical wound infection incidence and identify preoperative
risk factors that can influence in his appearance.
METHODS. Prospective, observational, multicentre study during a period of one year
(2006–2007) in 59 hospitals of Catalonia. Variables assessed: sex, age, weight (body mass
index), ASA, independence grade, alcohol and smoke habit, diabetes, respiratory, cardio-
vascular, renal, neurological and liver pathology, type of surgery, central catheter, nasogastric
tube, thoracic drainage, neoplastic disease, immunosuppression, sepsis, blood transfusion on
last week. v2 test and T student test were analysed.
RESULTS. 2,991 patients were studied. 50.7% male and 49.3% female; elective surgery
70.7%; emergency surgery 11.8% and ambulatory major surgery 17.5%; ASA I 30%, ASA II
52.2%, ASA III 16% y ASA IV 1.8%. About them, 13.7% suffered from postoperative
complications, 5% suffered from respiratory complications, 4.2% cardiovascular ones and
4.7% suffered from surgical wound infection. Next variables has been associated with a high
significance risk of surgical wound infection: ASA (P 0.000), independence grade (P 0.000),
acute respiratory process on last month (P 0.001), oxygenotherapy at home on last year (P
0.032), HTA (P 0.001), sever peripheral vascular pathology (P 0.027), renal failure (P 0.002),
diabetes (P 0.037), sepsis (P 0.001), coagulopathy (P 0.014), cardiovascular pathology (P
0.000) and neoplastic disease on last 5 years (P 0.000).
CONCLUSIONS. Co-morbidites clearly contribute to increase incidence of surgical wound
infection. It is important to identify risk patients and to emphasize the importance of good
patients preparation before surgery just as being accurately in the intraoperative management
in order to decrease surgical wound infection.
REFERENCE(S). 1. Woodfield JC, Beshay NM, Pettigrew RA, Plank LD, van Rij AM
(2007) American Society of anesthesiologists classification of physical status as a predictor of
wound infection. ANZ J Surg 77(9):738–741. 2. Owens CD, Stoessel K (2008) Surgical site
infections: epidemiology, microbiology and prevention. J Hospital Infect 70(suppl 2):3–10.
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THE IMPACT OF AN ANTIBIOTIC POLICY CHANGE ON CLOSTRIDIUM
DIFFICILE INFECTION IN A UK TEACHING HOSPITAL INTENSIVE CARE UNIT
A. Miller1, B. Carr1
1University Hospital of North Staffordshire, Intensive Care, Stoke-on-Trent, UK
INTRODUCTION. Clostridium difficile infection (CDI) can cause diarrhoea, dehydration,
pseudomembranous colitis, toxic megacolon, intestinal perforation and death. It has been
shown to increase mortality and length of stay in critically ill patients. The critically ill are at
particular risk of acquiring CDI. CDI is associated especially with use of third generation
cephalosporins, clindamycin and prolonged use of aminopenicillins. Carbapenems have also
recently been associated with CDI. Fluroquinolones may have contributed to more resistant
strains. There has been an increase in CDI rates from 1990. This increase became more rapid
in the late 1990s and early 2000s. Government and media focus on the problem in recent years
has encouraged the development of, and adherence to, national guidelines and a resultant fall
in CDI is now becoming evident in the UK. One of the Health Protection Agency’s key
recommendations for reducing rates of CDI is restrictive antibiotic guidelines. Antibiotic
prescribing policy was changed in The University Hospital of North Staffordshire in Sep-
tember 2007, shifting from the predominant use of third generation cephalosporins and
quinolones to aminopenicillins and aminoglycosides.
OBJECTIVES. To review whether rates of CDI were reduced in Intensive Care patients with
the introduction of a restrictive antibiotic prescribing policy.
METHODS. Databases of health care associated infections (HCAI) were reviewed and the
number of positive Clostridium difficile results were noted. Patients were excluded if they
were admitted with CDI. Two time periods were compared, before and after the antibiotic
prescribing policy change. During the reviewed time periods no other significant changes
were implemented in regard to reducing CDI or other HCAIs.
RESULTS. In the 17 months prior to the antibiotic change 37 out of 998 patients had CD
detected. In the 16 months after only 11 out of 1,134 patients had CD detected. This repre-
sents a 73.8% fall in CDI since the antibiotic policy change.
CONCLUSIONS. Several studies and a systematic review show that CDI can be reduced by
restricting cephalosporins and clindamycin. Our data demonstrate a dramatic reduction in CDI
in our ICU with a fundamental change in antibiotic prescribing. The fall in CDI in our unit is
double the fall in CDI rates in the UK. We encourage all ICUs to take up the Health
Protection Agency’s recommendation for antibiotic prescribing.
REFERENCE(S). 1. Ang et al. 2008; Biller et al. 2007; Davey et al. 2006; Department of
Health; Fowler et al. 2007; Goorhuis et al. 2007; Health Protection Agency; Itani et al. 2006;
Kuijper et al. 2006; Lawrence et al. 2007; Loo et al. 2005; McFarland et al. 1989; National
Clostridium difficile Standards Group 2004; Saxton et al. 2007; Settle et al. 1998; Stone et al.
2000; Thomas et al. 2003; Valiquette et al. 2007; Warny et al. 2005; Wilcox et al. 2004.
GRANT ACKNOWLEDGEMENT. N/A.
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HOW MANY ICU PATIENTS RECEIVE ANTIFUNGAL THERAPY? RESULTS
FROM FONGIDAY: A ONE-DAY PREVALENCE STUDY IN 169 ICUS
E. Azoulay1, H. Dupont2, J.-P. Stahl3, A. Tabah4,5, O. Lortholary6, C. Martin7, A. Franc¸ais5,
B. Guidet1, J. F. Timsit4,5
1Saint Louis University Hospital, Medical Intensive Care Unit, Paris, France, 2North Uni-
versity Hospital, Anesthesia—Intensive Care, Amiens, France, 3Grenoble University
Hospital, Infectious Diseases, Grenoble, France, 4Grenoble University Hospital, Medical
Intensive Care Unit, Grenoble, France, 5Albert Bonniot Institute, INSERM U823, La Tron-
che, France, 6Necker University Hospital, Infectious Diseases, Paris, France, 7North
University Hospital, Anesthesia - Intensive Care, Marseille, France
INTRODUCTION. Invasive Candida infection is a difficult to diagnose life threatening
disease. Low sensitivity of available diagnostic tools and long delay to positivity of blood
samples has lead to the development of prophylactic and preemptive treatment strategies for
ICU patients.
OBJECTIVES. To assess prevalence and factors associated with systemic antifungal therapy
(SAT) administration in critically ill patients.
METHODS. One day (9 December 2008 = Fongiday) cross sectional study involving 169
ICUs (53% University-hospitals, 63.7% polyvalent, 20.8% medical and 16.7% surgical,
13.7% pediatrics and neonatology). We recorded center and patient characteristics, Candida
colonization and infection, as well as SAT administration at Fongiday and at day 28.
RESULTS. Among the 2047 patients, 154 (7.5%) were receiving SAT. 16 patients were
treated for other fungal infection (mostly aspergillosis). In the remaining treated patients,
reasons for SAT included: 27.5% proven candidiasis, 18% empiric therapy in patients with
risk factors for candidemia, 17% prophylaxis, 34.8% preemptive, and 13% because of
hemodynamic instability. SAT consisted in fluconazole in 40.8%, Caspofungin in 23.5%,
Voriconazole in 8.5%, and liposomal amphotericin in 5.9%.
Documented Candida species included: 48% albicans, 7% glabrata, 2.6% parapsilosis, 1.3%
krusei, 1.3% kefir, and 19.5% other or unknown species.
Independently of patient based risk factors for receiving SAT (emergency surgery admission,
malignant hemopathy, Candida colonization, in ICU use of steroids, severe sepsis); ICU based
variables associated with the use of SAT were: smaller institutions (\800beds), with organ
transplant activity, higher incidence of ICU acquired candidemia and prescription habits such
as high use of fluoroquinolones or fewer cost considerations in treatment decisions and local
habits for preemptive and empirical therapy.
Even though patients receiving SAT were sickest (saps II 52.1 vs. 43.4; P \ 10-4), had a
longer ICU stay (13 vs. 7 days; P \ 10-4), received more immunosuppressive therapy (56.5
vs. 23%; P \ 10-4) and were more frequently colonized with Candida (63.6 vs. 8.6%;
P \ 10-4); outcomes were similar in both groups. Day 28 mortality was 19.5% [SAT group
20.1%; no SAT: 19.5%; HR 0.86 (0.59–1.27); P = 0.46].
CONCLUSIONS. SAT are prescribed in 7.5% of ICU patients, chiefly fluconazole and
caspofungin. Only less than 25% of these patients have a sound SAT indication, other patients
receive SAT on the basis of risk factors for candidemia, or as a preemptive indication. SAT
patients are sickest and expected to die more frequently than patients without SAT, but
mortality is not different, suggesting a benefit from SAT and leaving a place for further
evaluation.
GRANT ACKNOWLEDGEMENT. Promotion: SRLF, SFAR, INSERM, SPILF. Grant:
Pfizer.
Communication in the ICU: 0802–0806
0802
HOW CAN WE IMPROVE COMMUNICATION BETWEEN THE INTENSIVE
CARE UNIT (ICU) AND PRIMARY CARE?
M. Varrier1, A. Myers2, F. Baldwin1
1Royal Sussex County Hospital, Brighton, UK, 2Royal Surrey County Hospital, Guildford,
UK
INTRODUCTION. When a patient is admitted to the ICU it can be a distressing and
confusing time. Following discharge, it is often the GP who will be faced with difficult
questions regarding the admission and also with managing long-term sequelae of critical
illness. Intensive communication carried out during admission can have a positive effect on
outcome [1]. It is imperative for patient care that we also ensure optimum communication
between healthcare professionals after discharge from ICU.
OBJECTIVES. This survey was designed to identify areas where communication could be
improved between The Royal Sussex Hospital ICU and General Practitioners in the Brighton
and Hove area.
METHODS. All 250 individual GPs in the Brighton and Hove Primary Care Trust were
contacted via the practice managers and consulted using an online multiple-choice survey
hosted by Surveymonkey. 59 GPs responded (24%).
RESULTS.







When one of your patients is admitted to the
ICU would you like to be informed by
fax?
78 10 12
Would you like to receive a faxed discharge
summary when the patient is discharged
from ICU?
81 12 7
Would you also like to receive a discharge
summary if the patient dies in addition to
the information currently faxed to you by
the bereavement office?
78 12 10
Would you like an update on what’s new in
ICU on a GP Refresher day?
44 31 25
Do your patients who have been on the ICU,
or their relatives, have unanswered
questions following their stay?
29 19 52
Would you like to have someone to contact in
the event of any unanswered questions?
85 7 8
Do your patients who have been on ICU have
continuing rehabilitation needs after
discharge?
66 9 25
Do you think any of your patients would
benefit from an ICU follow up clinic?
34 14 52
CONCLUSIONS. GPs were highly in favour of receiving simple communications from ICU,
i.e. Faxed notification of patient admission or discharge, a faxed discharge summary if a
patient dies in ICU, and a point of contact in the event of unanswered questions post-
discharge. However, few GPs find their patients have unanswered questions following a stay
in ICU. Although most GPs feel their patients have continuing rehabilitation needs, few feel
that a follow-up clinic would be of value.
REFERENCE(S). 1. Lilly CM, Sonna LA, Haley KJ, Massaro AF (2003) Intensive com-
munication: Four-year follow-up from a clinical practice study. Critical Care Medicine.
Ethical Issues Criti Care 31(5):S394–S399
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MORTALITY AS A QUALITY INDICATOR OF ICU RESULTS AND A QUALITY
INDICATOR OF ORGAN PROCUREMENT PROGRAMS. IMPACT OF A MODEL
OF CATEGORIZATION OF PATIENTS AT ADMISSION IN ICU
J.-M. Dominguez-Roldan1, P.-I. Jimenez-Gonzalez1, C. Garcia-Alfaro1,
F. Hernandez-Hazan˜as1, M.-L. Gascon-Castillo1, M.-D. Freire-Aragon1, F. Murillo-Cabezas1
1Hospital Virgen del Rocio, UCI-HRT, Sevilla, Spain
INTRODUCTION AND OBJECTIVES. Mortality is a Quality Indicator of ICU (high
mortality means bad results). Detection of brain dead patients in ICU is Quality Indicator of
donation programs (high number of brain dead detected means good result of the program).
The objective of this research was to analyze if the use of a Model of Categorization of
Patients at admission in ICU can make compatible both antagonist Quality Indicators.
METHODS. A continuous series of 621 patients admitted in a neurological ICU were
included. All patients were classified at admission in ICU in one of these categories (Catg.):
Catg. 1: Critical ill patient, needing intensive care monitoring and therapeutic; no limit in the
treatment. Catg. 2: Similar to Catg. 1, but no active treatment at admission, Catg. 3: like Catg.
1, excepting some level of therapeutic limit because co-morbilities, Catg. 4.: Admitted in ICU
but could also be managed in the ward (too much healthy for ICU), Catg. 5: Admitted in ICU
but too sick to benefit from ICU care (specific neurological criteria for Catg. 5, based on
clinical and CT scan data, was performed). The influence of categorization in the number of
potential donors detected, and the global results of the ICU were analyzed. A statistic analysis
of proportions of brain death due to admission of Categ. 5 was performed.
RESULTS. The main group of patients of brain dead patients was Spontaneous Intracerebral
Hemorrhage and Subarachnoid Hemorrhage.
MORTALITY OF PATIENTS ACCORDING CATEGORIES
Number of patients Dead patients Brain dead patients
Categories 1–4 605 80 47
Categorie 5 16 16 16
Total 621 96 63
Global mortality (15.45%) compared with Mortality without Categ. 5 (13.88%): no significant
statistical difference (P = 0.26). Brain death including all categories (N = 63) compared
with brain death excluding Catg. 5 (N = 47) significant difference (P \ 0.001).
CONCLUSIONS. The use of a Model of Categorization of Patients at admission of patients in
ICU make compatible the use of Mortality as an Quality Indicator of ICU and also as a Quality
Indicator in organ procurement programs. Its use helps to demonstrate the non significant
increase of global mortality and relevant increase of the number of organs potential donors.
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DETERMINANTS OF FAMILY SATISFACTION IN THE ICU
K. Sundararajan1
1Royal Adelaide Hospital, ICU, Adelaide, Australia
It has previously been demonstrated that the families of patients dying in the ICU report
higher satisfaction with their ICU experience than the families of survivors. The aim of this
study was to explore the determinants of family satisfaction of patients in an Australian ICU
population.
A total of 108 consecutive patients, staying [48 h in a mixed, level 3 ICU were identified.
Eight were excluded because next of kin contact details were unavailable. A written ques-
tionnaire was posted to next of kin 4 weeks after ICU discharge. Subjects who had not
responded after 4 weeks were then contacted by phone, consent was sought, and, if given, a
phone questionnaire was performed. Family satisfaction was measured using a 10 item
questionnaire incorporating visual analogue scales.
Seven subjects refused to participate. 59 responded by post and a further 25 agreed to a phone
interview. Thus a total of 84 family members were included, 73 of patients who survived, and
11 whose relative died in ICU. Overall family satisfaction was high (mean scores 6.8–8.1).
Highest scores recorded were for communications with nursing staff (8.1 ± 2.2), lowest score
for communication with medical staff (6.8 ± 2.6). Ten (12%) families had mean overall
scores \5. There was no difference in the satisfaction scores between families of survivors
and non-survivors.
0805
ICU RESEARCH: WHO SHOULD CONSENT?
F. Gigon1,2, C. Chenaud1,2, P. Merlani1,2, B. Ricou1,2
1Geneva University Hospitals, Service of Intensive Care, APSI, Geneva, Switzerland, 2Uni-
versity of Geneva, Geneva, Switzerland
INTRODUCTION. Informed consent (Ic) for research in the particular context of ICU is
controversial, even for conscious patients. Preferences of patients and relatives regarding its
modalities were rarely investigated. We sought to explore whether they differed for patients
and relatives according to the invasiveness of the study proposed or the consciousness of the
patient.
METHODS. Patient and relative’s pairs were randomized to express their opinion about Ic’s
modalities for either a non-invasive (NIS, i.e retrospective data extraction) or an invasive
study (IS, i.e. prospective drug trial). Similar questions were addressed for a conscious and an
unconscious patient. The questionnaire was distributed shortly after ICU discharge.
RESULTS. Of 553 eligible patients, 185 (33%) patients and 125 relatives of these patients
(68%) responded. If conscious, most patients thought they were the person to be asked the Ic
{NIS: 69/93(74%); IS: 64/92(70%)}. For NIS, 7 (8%) thought the physicians could consent or
that no consent was necessary, and 6 (7%) that the relatives could. If unconscious, the patients
would like the relatives to give Ic, differently depending on the invasiveness {NIS: 53(57%);
IS: 48(52%), P = 0.01}. ICU doctors were more sought in NIS {10(11%) vs. 0} whereas it
was the family doctors for IS {13 (14%) vs. 5 (5%)}. 9 (10%) for NIS and 8 (9%) for IS
choose waiving of consent. For conscious patient, most relatives thought patients were the
person to be asked the Ic {NIS: 44/64 (69%); IS: 42/61 (69%)}. They themselves came in
second position {NIS: 9 (14%); IS: 8(13%)}. For unconscious patients 2/3 of relatives thought
of themselves and then of ICU doctors {NIS: 9 (14%); IS: 8 (13%)}. A third of patients would
like a second person to consent, and 48% if unconscious and IS. More relatives wanted a
second person to give Ic for IS than for NIS: for conscious 36 (59%) versus 21 (33%)
(P = 0.0012); for unconscious 37 (61%) versus 23(36%) (P = 0.0068), respectively. Rates of
concordance between patients and relatives were of 64–80%. In emergency situation, less
patients agreed that the study starts before the Ic for IS than for NIS: for conscious 48 (52%)
versus 63 (68%) (P = 0.04); for unconscious 49 (54%) versus 61 (66%), respectively. 28
(46%) to 44 (69%) of relatives thought the study could start, depending on consciousness and
invasiveness. Most pairs agreed to consent in two steps, independently on consciousness or
invasiveness (64–75%).
CONCLUSION. ICU patients and relatives’ attitudes regarding Ic for research were different
according to patient’s consciousness. They were more protective with unconscious patients.
For conscious patients, most patients and relatives wanted the patient to consent. For
unconscious patients, about half of them wanted the relatives to decide. The others would like
to defer Ic to physicians (either ICU or family doctors). Invasiveness of the study impacted
significantly. On the whole, up to 10% choose waiving of consent.
0806
EVALUATION OF EMOTIONAL EXPERIENCE IN ICU PATIENTS
O. Edipoglu1, P. Cimen1, C. Kirakli1, D. Tatar1, S. Bilaceroglu1, A. Ozsoz1
1Izmir Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey
AIM. Psycholocigal problems are commonly encountered in critically ill patients. The aim of
this study was to evaluate the emotional experience of these patients during the period when
mechanical ventilation requirement ended and determine the relationship of this experience
with clinical and demographic parameters.
METHOD. Patients who had undergone mechanical ventilation (invasive or noninvasive)
and could be discharged from intensive care unit (ICU) were included in the study. All
patients were asked to read and answer the demographic data sheet and hospital anxiety
depression form. Patients who could not be able to answer these questionarries due to lack of
mental capacity, cooperation or educational level and patients who had psychiatric problems
were excluded. Then, anxiete and depression scores were calculated, and the relationship with
clinical and demographic parameters were evaluated.
RESULTS. Twenty-two patients with a median age of 52 (23–78) were evaluated. 31.8%
(n 7) of the patients were determined anxiete (median score: 7.27), and 45.5% (n 10) of the
patients were determined depression (median score: 7.13). There were no significant differ-
ences between the frequency of the anxiete and depression and the demographic features, ICU
days, and the duration of mechanical ventilation (P [ 0.05).
CONCLUSION. The data of this study have pointed that ICU patients significantly have
anxiete and depression. There was no relationship between the parameters and anxiete and
depression, maybe because of the handicap of the case numbers. So we should increase the
number of the cases and evaluate the emotional experiences of the critically ill patients
in ICU.
Muscle metabolism and endocrinology: 0807–0811
0807
MECHANISMS LINKING INSULIN RESISTANCE AND MUSCLE METABOLISM
IN SIRS: RESULTS OF A HUMAN OBSERVATIONAL STUDY
S. Weber-Carstens1, M. Braunschmidt1, A. Dimroth1, S. Wiesener1, T. Bobbert2, K. Mai2, M.
Boschmann3, J. Spranger2
1Charite´, Anesthesiology and Operative Intensive Care Medicine, Campus Virchow-Klini-
kum, Campus Mitte, Berlin, Germany, 2Charite´, Endocrinology, Diabetes and Nutrition,
Campus Benjamin Franklin, Berlin, Germany, 3Helios Klinikum and Medical Faculty of the
Charite´, Franz-Volhard Clinical Research Center, Berlin, Germany
INTRODUCTION. Insulin resistance is a common feature in critically ill patients. However,
tissue specific mechanisms of insulin resistance are not well understood. We aimed to
determine whole body insulin sensitivity and its impact on skeletal muscle metabolism in
patients during early course of critical illness.
METHODS. Prospective observational study in patients with a SOFA score C 8 on 3 days
within 7 days after ICU admission. We determined the insulin sensitivity index (ISI) during a
hyperinsulinemic-euglycemic clamp applying a continuous infusion with 100 mU/m2 insulin.
Steady state condition was defined at blood glucose levels (BGL) between 80 and 110 mg/dl
with a variation of less than 10% derived from four glucose measurements within a one hour
period. Tissue metabolites (glucose, lactate, pyruvate) were determined via a microdialysis
catheter inserted in the vastus medial muscle. All metabolites were analyzed every 20 min at
baseline (bs) and during steady state (ss) conditions of the clamp. To determine ex vivo
insulin stimulated cellular glucose uptake, we incubated undifferentiated human myosarcoma
RD18 cells 6 h in a medium containing 5% serum of the patients or controls. Medium was
changed to glucose-free medium before being incubated with 3H-2’Deoxy-glucose for
another 60 min. 3H-2’Deoxy-glucose uptake was measured in a betacounter. ISI and cellular
glucose uptake have been compared to 14 healthy controls matched by BMI, age and gender.
Data are given as median (25/75) percentile.
RESULTS. Hyperinsulinemic-euglycemic clamp was performed in 14 patients [multiple
trauma (n = 3), acute respiratory failure (n = 6), abdominal sepsis (n = 5)] 4.5 (2/6) days
after study enrolment. Median age was 55 (28/80), SAPS-II 58 (48.5/65) and SOFA 13.5(9.5/
15.8) upon ICU admission. BGL (ss) and insulin dosage (ss) were 84.2 mg/dl (74.5/92) and
15 IU/h (14.4/15.7) respectively in ICU patients. ICU patients revealed significant
(P \ 0.0001) insulin resistance compared to controls [ISI (M-value (mg/kg/min)/Insulin (mU/
ml))] = 0.02 (0.015/0.03) vs. 0.08 (0.04/0.11)]. Tissue glucose level in skeletal muscle
decreased significantly (P = 0.003) during clamp [49 mg/dl (33.3/77.3) at bs versus 34.3 mg/
dl (18.7/49.3) at ss]. Lactate, pyruvate tissue levels and lactate/pyruvate ratio in skeletal
muscle tissue remained unchanged [32.5 (23.2/46.5) vs. 37.1 (23.9/44.4)] during baseline and
at steady state respectively. In vitro investigation of insulin stimulated cellular glucose uptake
revealed significant impairment of insulin stimulated glucose uptake in ICU patients (22 vs.
3% insulin-induced increase in controls vs. ICU patients; P \ 0.01).
DISCUSSION. Critically ill patients show substantial whole-body insulin resistance during
early SIRS. The oxidative glucose metabolism of skeletal muscle tissue in vivo, however,
remains constant at that time, whereas circulating plasma mediators induce substantial
impairment of insulin-stimulated glucose uptake in vitro.
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SELECTIVE MYOSIN LOSS IN SKELETAL MUSCLE OF CRITICALLY ILL
PATIENTS
G. Hermans1, I. Vanhorebeek*2, S. Derde2, Y. Hedstro¨m3, P. J. Wouters2, F. Bruyninckx4, A.
D’Hoore5, L. Larsson3, G. Van den Berghe2
1University Hospitals Leuven, Medical Intensive Care Unit, Leuven, Belgium, 2University
Hospitals Leuven, Department of Intensive Care Medicine, Leuven, Belgium, 3Uppsala
University, Department of Clinical Neurophysiology, Uppsala, Sweden, 4University Hospitals
Leuven, Department of Physical Medicine and Rehabilitation, Leuven, Belgium, 5University
Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium, *Equally
contributed
INTRODUCTION. Critically ill patients frequently develop muscle weakness, which con-
tributes to adverse outcome and prolonged rehabilitation. This complication may arise from a
neurogenic and/or myogenic problem, but distinction between both is difficult using routine
diagnostic tools. In muscle biopsies of critically ill patients, selective loss of myosin protein
has been suggested to point to a myogenic component.
OBJECTIVE. We aimed to measure the myosin/actin ratio in skeletal muscle biopsies
obtained from a heterogeneous group of surgical and medical intensive care unit (ICU)
patients and from matched controls. We planned to study the myosin/actin ratio in relation to
the presence of abnormal spontaneous electrical activity, in relation to insulin therapy and use
of glucocorticoids.
METHODS. Secondary analysis of two large prospective single-center randomized clinical
studies in a surgical [1] and medical [2] ICU. Patients were randomised to strict blood glucose
control (80–110 mg/dl) with insulin or conventional glucose management, only starting
insulin if glucose level C215 mg/dl. Biopsies were taken from the rectus abdominis and/or
quadriceps muscle in critically ill patients and matched controls. Myosin/actin ratios were
determined using sodium dodecyl sulphate-polyacrylamide gel electrophoresis[3].
RESULTS. The myosin/actin ratio in muscle from critically ill patients was lower than in
controls. A severely reduced myosin/actin ratio (\1.5) was present in 18–32% of the patients
who were biopsied, and abnormal spontaneous electrical activity on electrophysiological
screening in 48–53%, whereas concomitant presence of both features was infrequent (10–
12%). Intensive insulin therapy appeared moderately protective against a severely reduced
myosin/actin ratio in rectus abdominis, but not vastus lateralis. Prolonged corticosteroid
administration was associated with a lower vastus lateralis myosin/actin ratio.
CONCLUSIONS. A low myosin/actin ratio and spontaneous electrical activity are often
present but only rarely co-occur in skeletal muscle from ICU patients, suggestive of distinct
pathophysiology. Intensive insulin therapy partially protected against, whereas prolonged
treatment with corticosteroids predisposed to, major selective loss of myosin in specific
skeletal muscles.
REFERENCE(S). 1. Van den Berghe G et al. Intensive insulin therapy in critically ill
patients. NEJM 2001. 2. Van den Berghe G et al. Intensive insulin therapy in medical
intensive care patients. NEJM 2006. 3. Larsson L et al. Loss of muscle myosin and acute
quadriplegia in patients treated with non-depolarizing neuromuscular blocking agents and
corticosteroids. Crit Care Med. 2000
GRANTS. Supported by the Flanders Research Foundation (G.0533.06) and the Research
Council of the Katholieke Universiteit Leuven (GOA2007/14). GVdB receives structural
research financing via the Methusalem program, funded by the Flemish Government.
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INCIDENCE AND RISK FACTORS OF HYPERTRIGLYCERIDEMIA IN AN
INTENSIVE CARE UNIT WITH ARTIFICIAL NUTRITION AND INTENSIVE
INSULIN THERAPY
M. R. Shams1, N. Tavassoli2, H. Plicaud1, M. Genestal1
1General ICU, GRCB 48, Anesthesiology and Critical Care Medicine Department, Purpan
University Hospital, Toulouse, France, 2Department of Clinical Pharmacology, Faculty of
Medicine, University of Paul Sabatier, Toulouse, France
BACKGROUND. A linear correlation between serum triglycerides and risk of intensive care
mortality was identified. Various clinical and metabolic situations (such as sepsis, renal
failure, hepatic failure, parenteral nutrition and administration of certain drugs) have been
associated with hypertriglyceridemia (HTG). It is well known that HTG is associated with
acute pancreatitis. Intensive insulin therapy (IIT) in patients requiring intensive care for more
than 7 days normalizes blood glucose levels and concomitantly partially restores the abnor-
malities in the serum lipid profiles and HTG.
AIMS. The aim of this study was to determine the incidence of HTG in patients receiving
artificial nutrition and IIT in an Intensive Care Unit (ICU), to describe their characteristics and
to establish the relevance of risk factors associated with HTG.
METHODS. This is a prospective, observational, cohort study performed in a General
Intensive Care Unit of Toulouse University Hospital (France) from 1st May 2007 to 31st July
2008. We included all consecutive intensive care patients with initial serum triglycerides level
of less than 3 mmol/L who received at least 7 days of artificial nutrition using enteral feeding
(hypercaloric hypernitrogenous with 80 g lipids (MCT) for 1,500 mL) by naso-gastric tube or
parenteral feeding [2,100 total kcal, 16 g N, 250 g glucose, 75 g lipids (MCT/LCT) for
2,000 ml], with at least three biochemical serum triglyceride analysis with one week interval
and IIT for tight glycemic control (6.1 mmol/L). v2 test and multivariate logistic regression
model were performed for statistical analysis. A total of 17 clinical factors were studied as
independent variables.
RESULTS. A total of 107 patients were included in the study. Administration lipid was
0.83 ± 0.36 g/(kg day) (theorical body weight). Incidence of HTG ([3 mmol/L) was cal-
culated as 17.9% per year. Multivariate analysis identified three independent risk factors for
HTG: age (P = 0.02; adjusted b-coefficient = -0.04), insulin dosage (P = 0.01; adjusted b-
coefficient = 0.83) and hepatic failure (total bilirubine [ 25 mmol/L) (P = 0.04; adjusted b-
coefficient = 1.27).
CONCLUSION. This study shows that ICU admitted patients receiving artificial nutrition
and intensive insulin therapy are prone to develop HTG. Hepatic failure and insulin infusion
rate were the most important risk factors for HTG. Age had a protective effect. Our results
raise three important matters: (1) serum triglycerides assessment is necessary in seriously ill
patients receiving artificial nutrition; (2) elevated triglycerides reflect the degree of insulin
resistance and severity of critical illness; (3) hypertriglyceridemic profile of young patients
admitted in ICU is very important to be considered.
0810
VITAMIN D DEFICIENCY IS HIGHLY PREVALENT IN CRITICALLY ILL
PATIENTS
K. Amrein1, S. Amrein2, A. Holl3, J. Plank1, H. Dobnig1
1Medical University of Graz, Department of Internal Medicine, Graz, Austria, 2Medical
University of Graz, Department of Anaesthesiology and Intensive Care Medicine, Graz,
Austria, 3Medical University of Graz, Department of Neurology, Graz, Austria
INTRODUCTION. Low vitamin D levels are associated with increased overall mortality
independently of major clinical risk factors. Vitamin D insufficiency and deficiency is present
in 30–50% of healthy adults. UV-B induced cutaneous synthesis is the main source of vitamin
D as opposed to only small quantities originating from dietary sources. The typical daily
amount of vitamin D3 given with enteral or parenteral nutrition to ICU patients who are
deprived of sunlight is 200 IU and thus lies well below the recommended doses.
OBJECTIVES. Our primary objective was to evaluate the prevalence of vitamin D defi-
ciency in critically ill patients at different intensive care units of a large tertiary care centre
during winter months.
METHODS. Vitamin D status [25-hydroxyvitamin D; 25(OH)D] was assessed at different
ICUs (medical, cardiothoracic, neurosurgical and neurological) in 129 patients (age
62 ± 14 years, 58% male) from September 2008 until April 2009.
RESULTS. The mean serum 25(OH)D level was 15.0 ± 7.6 ng/ml (reference range 30–
60 ng/ml). 75.2% of all patients had vitamin D deficiency (\20 ng/ml), a further 20.2%
vitamin D insufficiency ([20 and \30 ng/ml). Normal 25(OH)D levels ([30 ng/ml) were
found in only 4.6% of all patients. There was no significant difference in 25(OH)D levels
between the different ICUs (Fig. 1). Secondary hyperparathyroidism was prevalent in the
medical ICU only (median parathyroid hormone level of 72.1 pg/ml).
CONCLUSIONS. Average 25(OH)D levels are markedly low in critically ill patients. Based
on these results higher than current doses of vitamin D3 are recommended for supplemen-
tation. Before doing that, however, studies are needed to evaluate whether high-dose vitamin
D3 supplementation can normalise 25(OH)D levels and also affect outcomes such as mor-
bidity or mortality in an ICU setting.
0811
ADDITIONAL VALUE OF FREE CORTISOL MEASUREMENTS FOR THE
ASSESSMENT OF ADRENAL FUNCTION IN CRITICALLY ILL PATIENTS?
N. Molenaar1, A. N. Panneflek1, J. Groeneveld1, A. R. Girbes1, A. Beishuizen1
1VU University Medical Center, Department of Intensive Care and Institute for Cardiovas-
cular Research, Amsterdam, The Netherlands
AIMS. Immuno-assays for serum cortisol measure the total hormone concentration (serum free
cortisol plus the protein-bound fraction of cortisol). Free cortisol measurements could provide
a better reflection of circulating cortisol in patients with critical illness with a decreased
concentration of binding proteins. The aim of our study was to investigate the additional value
of free cortisol measurements in assessing adrenal function in the critically ill.
METHODS. A prospective study was performed in a tertiary medico-surgical intensive care
unit from December 2004 to March 2007, including 112 critically ill patients with a strong
clinical suspicion of critical illness-related corticosteroid insufficiency (CIRCI). After mea-
surement of baseline serum total cortisol, free cortisol (equilibrium dialysis) and
corticosteroid binding globulin (CBG), all patients underwent a conventional 250 lg ACTH
test. Post-stimulus total and free cortisol levels were determined at 30 and 60 min after the
administration of synthetic ACTH. The Coolens method was used for calculating serum free
cortisol concentrations.
RESULTS. Calculated free cortisol closely related to measured free cortisol at baseline
(r = 0.948) as well as for stimulated free cortisol increments (r = 0.77). Serum free cortisol
correlated well with serum total cortisol concentrations at baseline (r = 0.79, P \ 0.01), at 30
(r = 0.78, P \ 0.01) and 60 min (r = 0.78, P \ 0.01) and for stimulated cortisol increments
(r = 0.78, P \ 0.01). There was no difference in total cortisol concentrations in patients with
low CBG (CBG B 25 mg/L) and patients with higher CBG levels (CBG [ 25 mg/L). On the
other hand, in patients with low CBG levels free cortisol at baseline, and 30 and 60 min after
the ACTH-test were higher than those in normal CBG group (P \ 0.01 at all time-points).
However, the increment upon ACTH of free cortisol was not affected by low CBG. There was
no difference in total and free cortisol concentration at baseline in patients with low albumin
levels (\2.5 g/dl or \1.7 g/dl). Nor did low albumin affect the increment of free cortisol.
CONCLUSIONS. In assessing adrenal function in the critically ill, measurement of free cortisol
can be reliably estimated using the Coolens method. However, free cortisol has no additional
value over total cortisol for diagnosing CIRCI, when considering the delta-cortisol as a major
criterium. As expected, patients with low CBG had higher free cortisol concentrations for a given
total cortisol. However, the response to the ACTH test was not affected by low binding proteins,
in fact total cortisol increments closely paralleled free cortisol increments.
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INFLAMMATORY PARAMETERS IN HYPOTHERMIC PATIENTS DURING
POST-CARDIAC ARREST SYNDROME
L. L. A. Bisschops1, C. W. E. Hoedemaekers1, K. S. Simons1, J. G. van der Hoeven1
1Radboud University Nijmegen Medical Centre, Intensive care, Nijmegen, The Netherlands
INTRODUCTION. The prognosis of patients after return of spontaneous circulation after
cardiac arrest is mainly determined by the primary brain injury. Following global ischemia, a
number of cellular and molecular reactions initiate a cascade of events, resulting in neuronal
injury and death. The mechanisms leading to secondary neurological damage are complex
with multiple modulators, signaling pathways, enzymes, and proteins that may facilitate cell
death or survival. Cytokines play a critical role in cerebral ischemic injury, exhibiting both
neurotoxic and neuroprotective effects. The receptor for advanced glycation end products
(RAGE) is a member of the Ig superfamily of cell surface receptors and is present in the brain
on neurons, glia and endothelial cells. Both RAGE and its ligand high mobility group box 1
(HMGB1) play a role as mediators of ischemic inflammation and neurodegeneration. The aim
of our study was to study mediators of the systemic and cerebral inflammatory response in
patients treated with mild hypothermia after cardiac arrest.
METHODS. A prospective study was performed in ten comatose patients after cardiac arrest.
All patients were treated with mild hypothermia (32–34C) for 24 h, followed by passive
rewarming to normothermia. IL-1b, IL-6, IL-8, TNF-a and HMGB1 levels were measured at
repeated intervals in arterial and jugular bulb blood samples. Results are expressed as median
(interquartile range). Changes in cytokine levels over time were analyzed with one-way
analysis of variance. Differences between groups were analyzed with two-way analysis of
variance. A P \ 0.05 was considered statistically significant.
RESULTS. IL-6 concentrations were low during hypothermia in both arterial and jugular
bulb samples [48 (28–66) and 50 (36–70) pg/ml], and increased during rewarming to 211
(153–407) and 211 (145–381) pg/ml respectively at 24 h (P \ 0.001).The systemic con-
centration of IL-8 decreased during admission from 35 (31–55) to 16 (15–18) pg/ml
(P \ 0.001). In the jugular bulb samples IL-8 decreased from 42 (27–65) to 18 (14–23) pg/ml
(P \ 0.001). HMGB-1 concentration on admission was increased in both arterial and jugular
bulb samples 1.98 (0.31–3.14) and 2.52 (0.27–2.92) ng/ml respectively. Levels decreased
over the next 48 h. TNF and IL-1b were below detection limits. There were no significant
differences in IL-6, IL-8 and HMGB-1 levels between arterial and jugular bulb samples at any
time point.
CONCLUSIONS. IL-6, IL-8 and HMGB-1 concentrations are increased after cardiac arrest.
We found no significant differences in IL-6, IL-8 and HMGB-1 concentrations between
arterial and jugular bulb samples suggesting a systemic inflammatory response as a con-
tributing factor to the post-cardiac arrest syndrome rather than an isolated cerebral
inflammatory response.
0813
NEUROLOGICAL OUTCOMES WITH EARLY OUT-OF-HOSPITAL INTRAVE-
NOUS ADRENALINE ADMINISTRATION BY EMERGENCY TECHNICIANS IN
THE MANAGEMENT OF CARDIOPULMONARY ARREST
T. Sakamoto1, A. Takasu1, N. Kaneko1, Y. Yanagawa1, Y. Kasuya2, J. Ohgawara2
1National Defense Medical College, Department of Traumatology and Critical Care, Tok-
orozawa, Japan, 2Tokorozawa FIre Department, Tokorozawa, Japan
INTRODUCTION. Although adrenaline is still a potentially useful drug for the patients with
cardiopulmonary arrest (CPA), it is still unclear whether the administration of adrenaline
during an early phase after CPA onset contributes to neurologically good outcomes or not. We
seek to investigate the benefit of the early administration of intravenous adrenaline on the
neurological outcomes of out-of-hospital CPA patients by authorized emergency medical
technicians (A-EMTs). In Japan, only A-EMTs are allowed to give intravenous adrenaline in
out-of-hospital CPA setting, while standard EMTs (S-EMTs) are not allowed. There are no
technical differences between the two types of EMTs except the procedure of intravenous
adrenaline administration.
METHODS. We experienced 348 sudden onset CPAs in patients more than 8 years old
between April 2006 and March 2008. Cardiopulmonary resuscitation (CPR) in accordance
with 2005 American Heart Association guideline was performed in all patients. We compared
demographics, ECG patterns at the scene, and Glasgow Outcome Categories (GOC) one
month after admission between patients that were given intravenous adrenaline at out-of-
hospital situation (OH group) and patients given intravenous adrenaline after arrival at a
hospital (AH group). There had more than one A-EMTs in the ambulances of OH group and
only S-EMTs in AH group. Comparisons between the two groups were made with Student t
test or v2 test. Good GOC was defined as GOC 1 or 2.
RESULTS. Of the total patients, 63 patients (18.1%) were in OH group. Adrenaline was
given at 22.3 ± 7.6 min after the patients’ collapse in OH group, which was 10 min earlier
than in AH group (P \ 0.05). There were no differences in age, cardiac causes, witnesses,
bystander CPR, ventricular fibrillation or pulseless ventricular tachycardia on the initial ECG
and survival in one month between the groups. Out-of-hospital return of spontaneous circu-
lation was higher (30.2 vs. 12.6% respectively, P \ 0.05) and good GOC was lower (0 vs.
6.7%, respectively, P \ 0.05) in OH group than AH group.
CONCLUSION. This study indicates that early adrenaline injection contribute to out-of-
hospital return of spontaneous circulation, but not to neurological recovery. Additional
investigations are needed for the trial of the drugs such as anti-diuretic hormone alone or in
combination with adrenaline.
0814
RAPID HYPOTHERMIA INDUCTION AFTER CARDIAC ARREST SHORTENS
ICU AND HOSPITAL STAY
P. Stammet1, C. Werer1, M. Max1
1Centre Hospitalier de Luxembourg, Intensive Care, Luxembourg, Luxembourg
INTRODUCTION. Optimal timing for the induction of therapeutic hypothermia (TH) after
cardiac arrest (CA) is still not definite. We wanted to determine a correlation between time to
target temperature (TTT) and outcome or length of stay (LOS) in these patients.
METHODS. We enrolled 73 consecutive patients admitted to the 18 bed mixed ICU in a
teaching hospital. Most patients (n = 43) have been secondarily addressed by primary care
centres for percutaneous cardiac intervention (PCI) after CA. TTT was defined from return of
spontaneous circulation to a core temperature of 33C. Patients were assigned to three
arbitrarily defined groups, according to their TTT, to study the influence of this time factor on
the LOS and outcome: fast (F) \ 180 min; medium (M) 181–300 min; slow (S) [ 300 min.
Cerebral performance score (CPC) was used for outcome measurement at the end of the
hospital stay.
RESULTS. Although there is no difference in outcome between the groups, LOS in the ICU
as well as in the hospital is significantly longer in the S-group compared to the F-group
(Table 1). Mean time from CA to hospital admission differed significantly for patients sec-
ondarily referred to our hospital versus those directly admitted to our hospital where optimal
temperature management started (106 ± 53 vs. 59 ± 43 min, P = 0.0001). Statistical anal-
ysis used Student’s t test, ANOVA and chi square tests.
















43% 45% 43% NS
Bad outcome
(CPC 3-4)
11% 13% 10% NS
Dead (CPC 5) 46% 42% 47% NS





17* 20 31* *Intergroup
ANOVA
P \ 0.05
CONCLUSION. Shorter TTT decrease LOS in ICU and hospital with a potential financial
impact, even without outcome improvement. If longer transportation times are encountered
prehospital cooling after CA should be promoted.
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CARDIAC ARREST IN FRANCE: SO COOL INTENSIVE CARE UNITS
D. da Silva1, J. Aboab2, C. Blayau1, C. Tassin1, J. Josserand1, S. Gaudry1, R. Sonneville1,
B. Re´gnier1, L. Bouadma1, M. Wolff1, B. Mourvillier1
1Centre Hospitalier Universitaire Bichat-Claude Bernard, Re´animation Me´dicale et Infectie-
use, Paris, France, 2Hoˆpital Raymond Poincare´, Re´animation Me´dico-Chirurgicale Adulte,
Garches, France
INTRODUCTION. According to French and international guidelines, mild therapeutic
hypothermia (MTH) is indicated in unconscious adult patients with spontaneous circulation
after out-of-hospital ventricular fibrillation cardiac arrest. Several surveys investigated the
implementation of MTH into clinical practice in ICU’s in several countries but not in France
yet.
METHODS. Based on the Directory of the Socie´te´ de Re´animation de Langue Franc¸aise
(French society of Intensive Care Medecine: SRLF) a senior doctor of each medical ICU was
contacted by telephone and was asked to take part in the survey concerning practice of MTH
after cardiac arrest in his unit.
RESULTS. 208 ICU (58 in Universitary Hospitals, 128 in General Hospitals and 22 in
Private Hospitals) accepted to take part in the survey, 13 could not be contacted despite
repeated phone calls, three refused to take part in the survey. 75% of ICU implemented MTH,
70% according to a protocol inspired from SRLF or ILCOR guidelines. 62% of ICUs man-
aged less than 20 cardiac arrest per year and 4% more than 50 cardiac arrest per year.
Concerning out-of-hospital cardiac arrest, MTH is consistently performed in 87% of ven-
tricular fibrillation or tachycardia and in 69% of pulseless electrical activity or asystole. MTH
was performed consistently in 60% of in-hospital cardiac arrest. The most employed methods
for MTH was the conventional method (ice packs, wet linen, ventilator) (68%), intravascular
cooling devices (13%) and water cooling blankets (8%). The satisfaction rates were respec-
tively 47, 86 and 58%. 41% used cold fluid infusion for induction of MTH. The core
temperature goal was 32–34C in 90%, monitored by rectal (29%), bladder (24%), or
oesophageal probe (22%), intravascular device (17%) or external device (8%). Rewarming
was passive in 79% of ICU after 12 h (6%) or 24 h (75%) of MTH.
MTH was not implemented in 25% of ICUs because of lack of experience (51%), technical
difficulties (35%), or lack of convincing studies (20%).
In multivariate analysis, implementation of MTH was significantly associated with the
presence of a written protocol concerning cardiac arrest management in the unit, teaching
hospital status and more than 11 bed ICU (P \ 0.05).
CONCLUSION. In contrast with previous North American and other European surveys,
MTH after cardiac arrest seems to be well implemented in France. The conventional method
of cooling is the most used but other methods seem to offer more satisfaction. A larger
diffusion of guidelines would probably improve implementation of MTH in cardiac arrest.
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SEDATION, ANALGESIA AND NEUROMUSCULAR BLOCKADE PROTOCOL
DURING THERAPEUTIC HYPOTERMIA. IT IS TIME FOR A CONSENSUS
C. Chamorro1, M. A. Romera2, B. Balandin2, M. Valdivia2
1Hospital Puerta de Hierro-Majadahonda, Intensive Care, Madrid, Spain, 2Hospital Puerta de
Hierro-Majadahonda, Madrid, Spain
AIM. Present practice guidelines recommend sedative-analgesic and neuromuscular blocker
(NMB) administration during therapeutic hypothermia in comatose patients after cardiac
arrest. However none of them suggest the possible best administration protocol. Inadequate
use of sedative and NMB agents prolongs recovery, delays time to reliable evaluation of
neurological status and prognosis and could increase complications. Also, paralytic agent
administration, without EEG monitoring, prevents seizure activity detection. The aim of this
study is to evaluate the different protocols used in published reports.
METHODS. A systematic literature review was conducted based on a MEDILINE/PubMed
search to identify all clinical studies published between January 1997–April 2009, with the
search terms: ‘‘therapeutic hypothermia’’ (TH) and ‘‘cardiac arrest’’. Selected articles had to
meet the following criteria to be included: TH use for improving neurologic outcome in coma
patients following cardiac arrest and specific mention of the sedative-analgesic and neuro-
muscular blockade protocol used during this treatment procedure. We checked the type of
drug and employed dose, the administration proposal, the specific neurologic and neuro-
muscular monitoring used and the complications detected.
RESULTS. We identified 35 studies, including 1,443 patients, which represent the protocol used
in 51 ICUs from different countries; 33 from 14 European countries; 9 from USA; 5 from
Australia; 2 from Japan; and 1 from Israel. In 9 ICUs there was no information about the specific
type of sedative used. In the rest midazolam was the most frequently used sedative; in 34 ICUs; at
doses between 5 mg/h and 0.3 mg/(kg h) and in 14 ICUs the midazolam dose was not specificied.
Propofol was used in 6 ICUs at doses up to 4 mg/(kg h); loracepam was used in 1 ICU and
ketamine in the other one. Sixteen ICUs (31%) did not use any analgesic during hypothermia and in
four the type of analgesic was not specificied. Fentanyl was used in 25 ICUs at doses between 0.5–
10 lg/(kg h); morphine was employed in 3 and buprenorphine, sufentanil and piritramide in the
other. NMBs were routinely used to avoid shivering in 38 ICUs and to treat shivering in 8; in 4 the
objective of its use was not specificied and in 1 ICU its use was discouraged. Pancuronium was
used in 20 ICUs, vecuronium in 8, cisatracurium in 7, rocuronium in 5, atracurium in 3 and in 7 the
NMB employed was not specificied. Only 2 ICUs used continuous monitoring of cerebral activity
during the hypothermia procedure, one with EEG, and in other one using the bispectral index. Two
ICUs used neuromuscular blocker administration guided by TOF monitoring.
CONCLUSION. There is a great variability in the protocols used. Very often the sedative
and the dose chosen do not seem the most appropriate for this procedure. Only two ICUs
routinely use EEG monitoring during paralysis. It is necessary to reach a consensus on this
specific critical care population.
Information from wide sample observational
studies: 0817–0821
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ANNUAL VOLUME OF MECHANICAL VENTILATION CONTRIBUTES TO
OUTCOME’S VARIABILITY AMONG INSTITUTIONS
M. Darmon1, S. Chevret1, J.-P. Fulgencio2, B. Guarrigues3, C. Gouzes4, P. Moine5,
D. Villers6, J.-R. Le Gall1, E. Azoulay1
1Saint-Louis University Hospital, Paris, France, 2Tenon University Hospital, Paris, France,
3Hoˆpital du Pays d’Aix, Aix en Provence, France, 4Ales Hospital, Ale´s, France, 5University of
Colorado, Denver, United States, 6Nantes-Hotel Dieu University Hospital, Nantes, France
INTRODUCTION. An increased volume of patients is associated with improved survival in
numerous high-risk medical conditions. Relationship between the number of patients admitted
(hospital volume) and outcome among patients requiring mechanical ventilation gave discordant
results [1, 2]. Our objective was to evaluate this relationship in a large population of patients.
METHODS. Prospective multicenter cohort study performed on the PMSI database. This
database provide diagnosis related groups (DRG) for all stays by inpatients in public or
private hospitals in France. All patients aged 18 or older who were admitted in the ICU in
2004 and 2005, and requiring conventional mechanical ventilation. Institutions with less than
100 admissions per year were not included in this study. Patients requiring only non invasive
ventilation were excluded from this study. Multivariate hierarchical mixed regression model
was used to adjust for confounders and for effect of clustering with institutions.
RESULTS. 179,197 patients receiving mechanical ventilation in 294 hospitals in 2004 and
2005 were included in this study. The median annual hospital volume was 162 patients
(interquartile range 99 to 282). Overall hospital mortality was of 31.4% ranging from 40.8%
in the lowest annual volume quartile (\99 patients) to 28.2% in the highest annual volume
quartile ([282 patients) (Fig. 1).
After adjustment for the severity of illness (SAPSII score), age, diagnosis related group, and
organ failure, an increase in hospital volume was associated with a significant reduction in
hospital mortality [OR: 0.9985 for each additional 10 patients treated (95% CI: 0.9978–
0.9992); P = 0.0001]. The multivariate mixed regression model identified persistence of a
significant centre effect after adjustments on volume effect (P \ 0.0001).
In predefined subgroups, the annual number of patients requiring mechanical ventilation for spe-
cific diseases, but not overall hospital volume, was significantly associated with hospital mortality.
CONCLUSIONS. Annual volume of patients receiving mechanical ventilation is associated
with increased survival. Persistence of significant differences in outcomes among centers after
adjustment on annual volume confirms that other determinants of centre effect are relevant
and also deserve further research.
REFERENCE(S). 1. Kahn JM et al. (2006) N Engl J Med 355(1):41–50. 2. Needham DM
et al. (2006) Crit Care Med 34(9):2349–2454.
GRANT ACKNOWLEDGEMENT. PHRC AOM04056.
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VOLUME-OUTCOME RELATIONSHIP FOR RENAL REPLACEMENT THERAPY
IN THE ICU
Y.-L. Nguyen1, E. B. Milbrandt1, L. A. Weissfeld1, J. M. Kahn2, J.-D. Chiche3, P. Aegerter4,
B. Guidet5, D. C. Angus1
1University of Pittsburgh, Medical Center, Department of Critical Care Medicine, Pittsburgh,
United States, 2University of Pennsylvania Medical Center, Division of Pulmonary, Allergy
and Critical Care, Philadelphia, United States, 3Hopital Cochin, Service de Reanimation
Medicale, Paris, France, 4Hopital Ambroise Pare, Departement de Biostatistiques, Boulogne-
Billancourt, France, 5Hopital Saint Antoine, Service de Re´animation Me´dicale, Paris, France
INTRODUCTION. Evidence suggests that patients requiring high risk procedures benefit from
care at institutions that provide a large volume of these procedures. A volume–outcome rela-
tionship is known for mechanical ventilation in the ICU, yet no one has examined this relationship
for renal replacement therapy (RRT). We examined this relationship in a large Parisian ICU
database, hypothesizing that mortality would decrease as annual RRT volume increased.
METHODS. We conducted an observational retrospective cohort study using CUB-REA, a
database of 40 ICUs in and around Paris, France. We selected all non-surgical adult patients
requiring RRT admitted to either a medical or combined medical-surgical ICU. We assessed the
association of annual RRT volume with ICU and hospital mortality using multivariable modeling
accounting for clustering and adjusting for age, co-morbidities, admitting diagnosis, SAPS-II, pre-
ICU length of stay (LOS), location before ICU admission, and hospital and ICU characteristics.
RESULTS. In our cohort, 9,449 patients received RRT. Median [interquartile range (IQR)]
age was 62 (49–73) years, SAPS II was 52 (40–71) and ICU and hospital LOS were 6 (2–14)
and 13 (5–28) days. The number of RRT cases per ICU per year varied considerably, from 3
to 128 (quartile1 = 3–17, quartile2 = 18–29, quartile3 = 29–58, quartile4 = 59–129). Of all
cases, 7.8% occurred in ICUs providing RRT less than 17 times per year. Mode of RRT most
commonly was intermittent (69%). The majority of RRT patients required mechanical ven-
tilation (62%) or vasopressors (62%). Less than 1/3 (28%) of patients had pre-admission renal
dysfunction. Overall ICU and hospital mortality were 45 and 49%, and did not vary by
quartile of annual RRT volume (lowest to highest volume, ICU mortality: 51.6, 45.1, 44.3,
44.2%; hospital mortality: 54.0, 48.5, 47.8, 48.6%). After adjusting for patient and hospital
characteristics, there was no association between annual RRT volume and either ICU or
hospital mortality whether we treated volume as a continuous measure or as quartiles.
CONCLUSION. In this preliminary analysis, though there were massive variations in annual
RRT volume per ICU, we were unable to demonstrate a volume–outcome relationship. One
possible explanation is that high RRT volume does not equate with expert provision of RRT.
Alternatively, the range of volume seen in CUB-REA, even on the low end, may have been
sufficient to provide ongoing RRT competency. Further analyses are planned to understand
reasons for our negative findings and to determine if other forms of organ support demonstrate
volume-outcome relationships in CUB-REA.
GRANT ACKNOWLEDGEMENT. Supported by the 2008 ECCRN Levi-Montalcini
Biomedical Science Award of the ESICM.
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CRITICAL CARE AND THE ELDERLY: THE UK EXPERIENCE
A. T. Jones1, C. A. Welch2, D. A. Harrison2, K. M. Rowan2
1Guy’s and St. Thomas’ Foundation Hospital, London, UK, 2ICNARC (Intensive Care
National Audit and Research Centre), Research, London, UK
INTRODUCTION. With national and international estimates indicating a marked increase in
elderly people over the coming decades and with a tendency towards more aggressive health
care for this age group, demand for critical care services is likely to increase. Significant gaps
exist in our knowledge about the role of critical care in the elderly population [1], which may
expose older patients to age-based biases [2]. With the UK Government publishing guidance
aimed at improving all care for older patients [3], we investigated what could be learned from
current provision of critical care to elderly patients to inform future planning.
METHODS. Data for 633,429 admissions to 188 adult, general critical care units in England,
Wales and Northern Ireland from January 1996 to December 2007 were extracted from the
Case Mix Programme Database. Admissions were grouped by age: 16–64, 65–74, 75–84 and
85? years. First, trends in numbers of elderly critical care admissions were compared with
population figures and second, case mix, outcome and length of stay were compared for
153,803 recent admissions (2006/2007).
RESULTS. Elderly admissions, aged 75? years, increased markedly from 1996/1997 to
2006/2007. The per capita increase was greater for those aged 75–84 and 85? compared with
those aged 16–64 and 65–74 years. Using recent data (2006/2007), admissions aged 75?
years accounted for just over one quarter of admissions, had similar severity to younger
admissions but were more likely to be admitted following emergency surgery (see Table 1).
Older patients had higher unit mortality, were more likely to die in the hospital following
discharge from critical care and were less likely to return to their normal residence. However,
overall, elderly admissions consumed similar critical care resources to younger admissions.









Admissions (%) 50.7 23.6 21.1 4.6
ICNARC physiology score
(mean)
17.1 18.7 19.6 19.3
Admission post emergency
surgery (%)
16.9 17.9 22.7 31.4
Death in critical care unita (%) 14.2 20.6 25.1 26.5
Post critical care unit in-
hospital deatha (%)
4.3 9.0 13.0 18.9
Return to normal residencea
(%)
63.8 58.3 48.7 40.1
Critical care unit LOS, days
(median)
2.0 2.2 2.1 1.8
aExcluding readmissions within the same acute hospital stay
CONCLUSIONS. Elderly admissions to UK critical care units are increasing. Information on
current provision of critical care, case mix and outcomes, could stimulate debate about future
provision.
REFERENCE(S). 1. Boumendil A et al. (2007) Should elderly patients be admitted to the
intensive care unit? Intensive Care Med. 33:1252–1262. 2. Garrouste-Orgeas M et al. (2006)
Decision-making process, outcome, and 1-year quality of life of octogenarians referred for
intensive care unit admission. Intensive Care Med. 32:1045–1051. 3. National service
framework for older people. London: Department of Health 2001.
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LIVER CIRRHOSIS AND INTENSIVE CARE, UNHAPPY BEDFELLOWS? AN
ANALYSIS OF ADMISSIONS TO ICU WITH CIRRHOSIS OVER A 12 YEAR
PERIOD FROM THE INTENSIVE CARE NATIONAL AUDIT & RESEARCH
CENTRE (ICNARC) DATABASE
A. O’Brian1, M. Singer2, D. Harrison3, C. Welsh3
1University Collge London, Institute of Hepatology, London, UK, 2University College
London, Bloomsbury Institute for Intensive Care Medicine, London, UK, 3Intensive Care
National Audit & Research Centre (ICNARC), London, UK
INTRODUCTION. Patients with liver cirrhosis admitted to intensive care (ICU) have a poor
prognosis. However, these studies are from single centres, that often provide transplantation [1].
We thus examined general ITU admissions with liver disease over 10-year period in units
contributing to ICNARC.
METHODS. Data was obtained for all adult patients considered to have cirrhosis (excluding
transplant) as a reason for admission or past medical history (PMH) from 626,953 admissions
to 192 general ICUs in England, Wales and Northern Ireland—1 December 1995–30 June
2008. More in depth data of sepsis (see [2] for definition), respiratory and renal support was
also obtained from 64,063 admissions to 87 ICUs 1 May 2003–29 April 2005 (Table 2) and
75 ICUs 15 April 2006–29 June 2008 (Table 3).
RESULTS. Cirrhosis accounted for 2.6% of admissions with a high hospital mortality[55%
(Table 1). The incidence of sepsis in patients with PMH of cirrhosis was high (28%). Further
analysis confirmed the high mortality of sepsis ? organ failure (up to 90%) compared to
sepsis alone (50–65%) and without sepsis (25–39%) (Tables 2, 3).
CONCLUSIONS. This is the largest study of ICU admissions with cirrhosis and confirms
high mortality and incidence of sepsis. Given the poor outcome, physicians must attempt to
prevent and treat sepsis in cirrhosis quickly and aggressively.
REFERENCE(S). 1. Cholongitas et al. (2006) Aliment Pharmacol Ther 23:883–893. 2.
Padkin et al (2003) Crit Care Med 31:2332–2338.








Number of admissions (% of total) 11,333 (1.8%) 4,763 (0.8%)
Age (years), mean (SD) 52.2 (13.1) 55.6 (14.3)
Sex (male), n (%) 7,036 (62.1) 2,825 (59.3)
APACHE II score, mean (SD) 19.0 (8.1) 22.0 (8.4)
Lowest mean arterial pressure
(mmHg), mean (SD)
62.3 (15.3) 62.0 (15.6)
Severe sepsis in first 24 h of
admission, n(%)
1,133 (10.0) 1,343 (28.2)







Critical care unit length of stay
(days), median (IQR) {non-
survivors-ns} {survivors-s}
2.2 (0.9 - 5.8);
{ns - 2.0(0.7
-5.9)}, {s - 2.3
(1.0 - 5.7)}
2.6 (1.0 - 6.6); {ns - 2.2
(0.8 - 6.1)}, {s - 2.8
(1.1 - 6.8)}
Total acute hospital length of
stay(days), median (IQR){non-
survivors-ns} {survivors-s}
12 (5 - 25); {ns - 8
(3 - 17)}, {s - 19
(10 - 36)}
15 (7 - 31); {ns - 10 (3
- 21)}, {s - 23 (13
- 44)}
[Overview]
Cirrhosis group Combination in 1st

























None (i.e. no episode of
sepsis, ventilation or
renalreplacement)
344 (28.0) 62 (18.0) 128 (39.1)
V 616 (50.2) 276 (44.8) 355 (61.1)
SV 89 (7.3) 50 (56.2) 55 (67.1)
VR 117 (9.5) 88 (75.2) 91 (83.5)





None 121 (22.2) 15 (12.4) 37 (33.6)
S 30 (5.5) 6 (20.0) 12 (52.2)
SV 79 (14.5) 45 (57.0) 48 (71.6)
VR 80 (14.7) 54 (67.5) 60 (87.0)
[Outcome of sepsis +/- organ failure (i)]
Cirrhosis group Combination in 1st



























217 (32.7) 26 (12.0) 51 (24.3)
V 306 (46.1) 129 (42.2) 162 (57.2)
SV 42 (6.3) 24 (57.1) 27 (65.9)
VR 63 (9.5) 49 (77.8) 56 (90.3)
Liver disease as past
medical history
None 97 (29.0) 14 (14.4) 33 (37.9)
S 25 (7.5) 7 (28.0) 12 (66.7)
V 112 (33.4) 37 (33.0) 53 (53.0)
SV 52 (15.5) 21 (40.4) 30 (62.5)
VR 27 (8.1) 16 (59.3) 15 (60.0)
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MULTICENTRE DATA NEEDED TO COMPARE NATIONAL SURVEILLANCE
SYSTEMS AND FORMULATE POLICY RECOMMENDATIONS ON ICU-
ACQUIRED PNEUMONIA
I. Morales1, A. Savey2, A. Lepape2, K. Mertens1
1Scientific Institute of Public Health, Epidemiology, Brussels, Belgium, 2Regional Nosoco-
mial Infection Coordinating Center for South East of France, Hospital Henry Gabrielle, Lyon,
France
INTRODUCTION. ICU nosocomial infections (NI) mortality exceeds three times that of
hospitals. NI frequency is determined by clinical practices, hospital hygiene strategies,
human resources, and surveillance activities. The related policies can be oriented by com-
paring similar ‘‘NI systems’’. By standardising definitions and indicators, the HELICS project
enabled the comparison of routine data from the Belgian (NSIH-ICU) and French (REA-SE)
networks.
OBJECTIVES. We aimed at identifying the needed data to advise NI control policies.
METHODS. A qualitative analysis of common indicators and a comparison of relevant
determinants and outputs of the 2006 French and Belgian reports on ICU-acquired pneu-
monia (PN) were performed to identify the missing relevant data.
RESULTS. Some PN indicators and determinants (antibiotics at admission, length of stay,
and frequency of intubation) were available as well as potential confounders (age, gender,
SAPS II score and patients’ origin). Only patients staying more than 2 days in the ICU were
included. Table 1 provides the main determinants and output indicators in both networks. In
France, the most frequent PN micro-organisms were S. aureus, P. aeruginosa, E. coli and H.
influenzae and in Belgium, P. aeruginosa, C. albicans, S. aureus and E. coli. MRSA repre-
sents 35.9% of all S. aureus (32.4% in Belgium). The most important but unrecorded data,
hampering comparative studies was the ICU PN case fatality rates. Data on average length of
AB treatment; hospital hygiene staff; national campaigns and ICU staff training would be
useful but were also missing.
CONCLUSIONS. Surveillance networks should consider operational control issues while
selecting the indicators to be collected. Data comparison revealed differences in PN
microbiological diagnosis technique which can bias frequency indicators. If PN detection is
less specific but more sensitive in Belgium, over-reporting cannot be discarded. Further
standardisation regarding diagnosis techniques is required. Different clinical practices may
explain longer stay in outliers French ICUs (higher mean but not median LOS), higher
intubation rate, use of antibiotics at admission, and NI risk. The related mortality excess in
French ICUs cannot be studied using routine data. Increased collaboration between epi-
demiologists, microbiologists and clinicians is necessary in (inter)national surveillance
efforts.





ICUs and (patients) 65 (17980) 26 (6125)
Mean age 61.2 66.2
Mean Lenght of stay (median) 11.1 (6) 7.8 (5)
Median SAPS II score 37 32
Antibiotics at admission (%) 50.3 44.4
Mean intubation days 10.5 3.3
Use of quantitative culture from minimally
contaminated specimen (%)
85.2 13.4
PN/1000 intubation days 16.9 13.7
Overall ICU mortality 17.2 7.3
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